Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of 2012 Bioequivalence Standards for Warfarin
NCT02574754Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- May 2016
- Primary completion
- Feb 2019
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of warfarin in Thromboembolism (TE), sponsored by University of California, San Francisco. Primary endpoint: Area Under the Plasma Concentration-Time Curve from 0 to 72 hours. Started May 2016; status: completed.
02
Drugs
warfarin
03
Conditions
Thromboembolism (TE)
Beyond the preview
Go deeper on NCT02574754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02574754.